Whanin Pharm Co (XKRX:016580) Total Liabilities : ₩53,047 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Total Liabilities?

Whanin Pharm Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩53,047 Mil.

Whanin Pharm Co's quarterly Total Liabilities increased from Sep. 2023 (₩40,203.65 Mil) to Dec. 2023 (₩43,019.15 Mil) and increased from Dec. 2023 (₩43,019.15 Mil) to Mar. 2024 (₩53,046.88 Mil).

Whanin Pharm Co's annual Total Liabilities declined from Dec. 2021 (₩35,963.19 Mil) to Dec. 2022 (₩35,446.44 Mil) but then increased from Dec. 2022 (₩35,446.44 Mil) to Dec. 2023 (₩43,019.15 Mil).

Whanin Pharm Co Total Liabilities Historical Data

The historical data trend for Whanin Pharm Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Total Liabilities Chart

Whanin Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

30,423.66

32,957.38

35,963.19

35,446.44

43,019.15

Whanin Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															45,557.64	41,851.57	40,203.65	43,019.15	53,046.88

Whanin Pharm Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Whanin Pharm Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40027.751	+	(307.056	+	2684.346
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	43,019

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	401226.633	-	358207.481
	=	43,019

Whanin Pharm Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	49719.66	+	(280.661	+	3046.558
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	53,047

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	415529.99	-	362483.111
	=	53,047

Whanin Pharm Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co (XKRX:016580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines